Two new reports from researchers at the University of Tennessee Health Science Center provide the first published description of unplanned interruptions in radiation cancer treatment across a major U.S. city in the COVID-19 era, according to their authors. The studies placed special focus on how risk for radiotherapy interruption varied by patient race, socioeconomic status, and home neighborhood.